Acquired by Inova Labs was acquired by ResMed in January 2016, signaling strong validation and potential alignment with ResMed’s distribution networks and joint sales opportunities for oxygen therapy solutions.

Oxygen Therapy Focus Specializes in respiratory illness devices, notably LifeChoice Activox POCs and Activox DUO2, offering clear cross-sell paths to providers and facilities seeking portable oxygen therapy solutions.

Mid-Mized Size Small to mid-sized team (51-200 employees) with ISO 13485 certification, suggesting agility with boutique account strategies while maintaining regulatory credibility for hospital and clinic deployments.

Revenue Window Reported revenue range of one to ten million dollars indicates room for growth through expanded product adoption, new markets, and channel partnerships within the medical device sector.

Expansion Potential Austin-based manufacturing and global tech stack indicate opportunity to collaborate on digital marketing, sales enablement, and international distribution through a unified platform with ResMed’s ecosystem.